These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
814 related items for PubMed ID: 15072770
1. Opportunistic amoebae: challenges in prophylaxis and treatment. Schuster FL, Visvesvara GS. Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770 [Abstract] [Full Text] [Related]
3. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Schuster FL, Visvesvara GS. Int J Parasitol; 2004 Aug; 34(9):1001-27. PubMed ID: 15313128 [Abstract] [Full Text] [Related]
4. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. Schuster FL, Guglielmo BJ, Visvesvara GS. J Eukaryot Microbiol; 2006 Aug; 53(2):121-6. PubMed ID: 16579814 [Abstract] [Full Text] [Related]
6. [Human pathology caused by free-living amoebae]. Scaglia M. Ann Ist Super Sanita; 1997 Feb; 33(4):551-66. PubMed ID: 9616966 [Abstract] [Full Text] [Related]
8. Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Visvesvara GS. Curr Opin Infect Dis; 2010 Dec; 23(6):590-4. PubMed ID: 20802332 [Abstract] [Full Text] [Related]
9. Amphizoic amoebae: pathogenic free-living protozoa; review of the literature and review of cases in Thailand. Siripanth C. J Med Assoc Thai; 2005 May; 88(5):701-7. PubMed ID: 16149694 [Abstract] [Full Text] [Related]
10. Infections with free-living amebae. Visvesvara GS. Handb Clin Neurol; 2013 May; 114():153-68. PubMed ID: 23829906 [Abstract] [Full Text] [Related]
11. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris. Kulsoom H, Baig AM, Siddiqui R, Khan NA. Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699 [Abstract] [Full Text] [Related]
12. Amebic infections of the central nervous system. Berger JR. J Neurovirol; 2022 Dec; 28(4-6):467-472. PubMed ID: 36098909 [Abstract] [Full Text] [Related]
13. Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis. Qvarnstrom Y, da Silva AJ, Schuster FL, Gelman BB, Visvesvara GS. J Infect Dis; 2009 Apr 15; 199(8):1139-42. PubMed ID: 19302010 [Abstract] [Full Text] [Related]
14. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS. Clin Infect Dis; 2003 Nov 15; 37(10):1304-12. PubMed ID: 14583863 [Abstract] [Full Text] [Related]
15. Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Schuster FL, Honarmand S, Visvesvara GS, Glaser CA. Clin Infect Dis; 2006 May 01; 42(9):1260-5. PubMed ID: 16586385 [Abstract] [Full Text] [Related]
16. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Hay J, Kirkness CM, Seal DV, Wright P. Eye (Lond); 1994 May 01; 8 ( Pt 5)():555-63. PubMed ID: 7835453 [Abstract] [Full Text] [Related]
17. Status of free-living amoebae (Acanthamoeba spp., Naegleria fowleri, Balamuthia mandrillaris) in drinking water supplies in Karachi, Pakistan. Yousuf FA, Siddiqui R, Subhani F, Khan NA. J Water Health; 2013 Jun 01; 11(2):371-5. PubMed ID: 23708583 [Abstract] [Full Text] [Related]
18. Infections Caused by Free-Living Amoebae. Kofman A, Guarner J. J Clin Microbiol; 2022 Jan 19; 60(1):e0022821. PubMed ID: 34133896 [Abstract] [Full Text] [Related]
19. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae. Rice CA, Colon BL, Chen E, Hull MV, Kyle DE. PLoS Negl Trop Dis; 2020 Sep 19; 14(9):e0008353. PubMed ID: 32970675 [Abstract] [Full Text] [Related]